Latest news
{{'2025-12-12T13:57:33Z' | dateFormatFilter}}
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
{{'2025-12-09T13:51:34Z' | dateFormatFilter}}
Novo Nordisk has completed its acquisition of Akero Therapeutics
{{'2025-11-26T13:00:00Z' | dateFormatFilter}}
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
